Mild asthma: an expert review on epidemiology, clinical characteristics and treatment recommendations
Open Access
- 14 May 2007
- Vol. 62 (6), 591-604
- https://doi.org/10.1111/j.1398-9995.2007.01394.x
Abstract
This review is the synthesis of a working group on mild asthma. Mild asthma includes intermittent and persistent mild asthma according to the Global Initiative for Asthma (GINA) classification, and affects between 50% and 75% of asthmatic patients. Mild asthma is more frequent, more symptomatic, and less well controlled in children than in adults. Cohort studies from childhood to adulthood show that asthma severity usually remains stable over time. Nevertheless, mild asthma can lead to severe exacerbations, with a frequency ranging from 0.12 to 0.77 per patient‐year. Severe exacerbations in mild asthma represent 30–40% of asthma exacerbations requiring emergency consultation. In mild asthma, inflammation and structural remodelling are constant, of varying intensity, but nonspecific. Therapy with inhaled corticosteroids (ICS) decreases bronchial inflammation, but has only a slight effect on structural remodelling, and, when stopped, inflammation immediately recurs. Permanent low‐dose ICS therapy is the reference treatment for persistent mild asthma. Effectiveness is to be reassessed at 3 months, and if it is insufficient the patient is no longer considered mildly asthmatic, and treatment has to be stepped up. As mild asthma is the most frequent form of the disease, diagnosis and management require physicians’ particular attention.Keywords
This publication has 90 references indexed in Scilit:
- Children with stable asthma have reduced airway matrix metalloproteinase-9 and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratioClinical & Experimental Allergy, 2005
- Montelukast, Compared With Fluticasone, for Control of Asthma Among 6- to 14-Year-Old Patients With Mild Asthma: The MOSAIC StudyPEDIATRICS, 2005
- Costs of hospitalization for severe acute asthma of patients not treated according to guidelines and recommendationsThe European Journal of Health Economics, 2005
- Altered protein tyrosine phosphorylation in asthmatic bronchial epitheliumEuropean Respiratory Journal, 2005
- Can endobronchial biopsy analysis be recommended to discriminate between asthma and COPD in routine practice?Thorax, 2004
- Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthmaJournal of Allergy and Clinical Immunology, 2003
- Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health surveyBMJ, 2002
- Proliferation and activation of bronchial epithelial cells in corticosteroid-dependent asthmaJournal of Allergy and Clinical Immunology, 2001
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaThe New England Journal of Medicine, 1992
- Reduction of budesonide after a year of increased use: A randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintainedJournal of Allergy and Clinical Immunology, 1991